Thymic hyperplasia in patients with Graves’ disease
Graves’ disease (GD) is commonly associated with other autoimmune conditions, and there is also a rare but well documented association between GD and thymic hyperplasia (TH). It is hard to say the real frequency of this latter association because most cases remain asymptomatic and are consequently not thoroughly investigated.
Materials and Methods
We reviewed the literature on GD-related thymus enlargement and found 107 cases published to date. Thymic cancer was only documented in four patients, while the majority of cases were diagnosed as TH. The causative mechanisms behind TH associated with GD have yet to be fully elucidated. Several studies support the hypothesis of a TSH receptor antibody (TRAb) mediating thymic enlargement.
We report on a female GD patient with an incidentally discovered anterior mediastinal mass. Our case is not consistent with the hypothesis of a TRAb-mediated mechanism because the thymus reached its largest volume at the onset of GD and shrank during remission of GD under medical treatment, despite persistently positive TRAb levels.
We support the hypothesis that two different pathogenic mechanisms might be responsible for thymus enlargement: thymic cortical tissue expansion seems to be due to a hyperthyroid state, while lymphoid hyperplasia appears to correlate with immune abnormalities underlying GD.
KeywordsGraves’ disease Thymic hyperplasia TSH receptor antibody (TRAb)
Conflict of interest
The authors do not have any conflicts of interest.
- 3.Halsted WS (1914) Significance of the thymus gland in Graves’ disease. Bull Johns Hopkins Hosp 25:223–224Google Scholar
- 5.Murakami M, Hosoi Y, Negishi T, Kamiya Y, Miyashita K, Yamada M, Iriuchijima T, Yokoo H, Yoshida I, Tsushima Y, Mori M (1996) Thymic hyperplasia in patients with Graves’ disease. Identification of thyrotropin receptors in human thymus. J Clin Invest 98:2228–2234PubMedCentralPubMedCrossRefGoogle Scholar
- 7.Michie W, Gunn A (1966) The thyroid, the thymus and autoimmunity. Br J Clinic Pract 20:9–13Google Scholar
- 9.Deforges-Bullet V, Petit-Aubert G, Collet-Gaudillat C, Cerceau R, Fraleu-Louer B, Meckenstock R, Greder A, Cordoliani Y, Beressi JP (2011) Thymic hyperplasia and Graves’ disease: a non-fortuitous association. Case report and review of literature. Annales d’Endocrinologie 72:304–309CrossRefGoogle Scholar
- 12.Suh H, Rosen JE, Doherty GM, Sauders BD, McAneny D (2013) Graves’ disease and thymic hyperplasia. Surgery 154:1473–1477Google Scholar
- 16.Hamzaoui A, Kilii R, Salem R, Kochtali I, Golli M, Mahjoub S (2012) Thymic hyperplasia in a patient with Graves’ disease. Int Arch Med 9:5–6Google Scholar
- 31.Iitaka M, Miura S, Yamanaka K, Kawasaki S, Kitahama S, Kawakami S, Oosuga I, Wada S, Katayama S (1998) Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves’ disease and Hashimoto’s thyroiditis. J Clin Endocrinol Metab 83:3908–3912PubMedGoogle Scholar
- 38.Volpé R (1979) Auto-immunity in the Endocrine System. Springer, BerlinGoogle Scholar